Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals And A Major Tech Stock On CNBC's 'Final Trades'
On CNBC's “Halftime Report Final Trades,” Joshua Brown of Ritholtz Wealth Management said under $30, Pfizer Inc. PFE is a gift. Pfizer is looking to build on the success of its COVID-19 vaccine rollout by introducing a direct-to-consumer medicines …